Castañeda-Hernández G - Search Results

1

In vitro antigiardial activity of IRE-6A and IRE-7B, two ethyl-phenylcarbamate derivatives.

Jiménez-Cardoso E, Flores-Luna A, Angeles E, Martínez P, López-Castañares R, Castañeda-Hernández G, Pérez-Urizar J. Jiménez-Cardoso E, et al. Rev Invest Clin. 2003 Jul-Aug;55(4):444-7. Rev Invest Clin. 2003. PMID: 14635610

2

Evidence for a postsynaptic action of the serotonergic anxiolytics: ipsapirone, indorenate and buspirone.

Fernández-Guasti A, López-Rubalcava C, Pérez-Urizar J, Castañeda-Hernández G. Fernández-Guasti A, et al. Brain Res Bull. 1992 Apr;28(4):497-501. doi: 10.1016/0361-9230(92)90095-f. Brain Res Bull. 1992. PMID: 1352175

3

Pharmacokinetics of oral ranitidine in Mexicans.

Castañeda-Hernández G, Flores-Murrieta FJ, Granados-Soto V, Herrera-Abarca A, Pérez-Urizar J, Herrera JE, Hong E. Castañeda-Hernández G, et al. Arch Med Res. 1996 Autumn;27(3):349-52. Arch Med Res. 1996. PMID: 8854394

4

Comparison between Sprague-Dawley and Wistar rats as an experimental model of pharmacokinetic alterations induced by spinal cord injury.

García-López P, Pérez-Urizar J, Ibarra A, Grijalva I, Madrazo I, Flores-Murrieta F, Castañeda-Hernández G, Guízar-Sahagún G. García-López P, et al. Arch Med Res. 1996 Winter;27(4):453-7. Arch Med Res. 1996. PMID: 8987177

5

Oral paracetamol bioavailability in rats subjected to experimental spinal cord injury.

García-López P, Pérez-Urizar J, Madrazo I, Guízar-Sahagún G, Castañeda-Hernández G. García-López P, et al. Biopharm Drug Dispos. 1997 Apr;18(3):203-11. doi: 10.1002/(sici)1099-081x(199704)18:3<203::aid-bdd11>3.0.co;2-f. Biopharm Drug Dispos. 1997. PMID: 9113343

6

Relationship between pharmacokinetics and the antinociceptive effect of indomethacin in the rat.

Flores-Murrieta FJ, Flores-Picazo Y, Pérez-Urizar J, Granados-Soto V, López-Muñoz FJ, Castañeda-Hernández G. Flores-Murrieta FJ, et al. Proc West Pharmacol Soc. 1997;40:111-3. Proc West Pharmacol Soc. 1997. PMID: 9436229 No abstract available.

7

Current bioequivalence criteria are adequate for oral cyclosporin A formulations.

Castañeda-Hernández G, Pérez-Urizar J, Medeiros M. Castañeda-Hernández G, et al. Ther Drug Monit. 1998 Dec;20(6):722-3. doi: 10.1097/00007691-199812000-00025. Ther Drug Monit. 1998. PMID: 9853995 No abstract available.

8

Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: therapeutic and pharmacoeconomic perspectives.

Aguilar Ponce JL, Flores-Picazo Y, Pérez-Urizar J, Castañeda-Hernández G, Zinser-Sierra JW, Dueñas-González A, Calderón-Flores E, Segura-Pacheco BA, de la Garza-Salazar J. Aguilar Ponce JL, et al. Arch Med Res. 1999 May-Jun;30(3):212-5. doi: 10.1016/s0188-0128(99)00014-7. Arch Med Res. 1999. PMID: 10427872

9

Limited sampling model for area-under-the-curve monitoring in pediatric patients receiving either Sandimmune or Neoral cyclosporin A oral formulations.

Medeiros M, Pérez-Urizar J, Muñoz R, Castañeda-Hernández G. Medeiros M, et al. Pediatr Transplant. 1999 Aug;3(3):225-30. doi: 10.1034/j.1399-3046.1999.00037.x. Pediatr Transplant. 1999. PMID: 10487284 Clinical Trial.

10

Activation of adenosine A1 receptors facilitates the analgesic effect of ketorolac and ketorolac-caffeine combinations in the rat.

Pérez-Urizar J, Aguirre-Bañuelos P, López-Muñoz FJ, Castañeda-Hernández G, Granados-Soto V. Pérez-Urizar J, et al. Proc West Pharmacol Soc. 1999;42:55-8. Proc West Pharmacol Soc. 1999. PMID: 10697689 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page